CFO’s Tax‑Driven Share Sale at ADLAI NORTYE Not a Red Flag for Growth
Adlai Nortye CFO’s tax‑driven sale of 12,667 ADS is a routine liquidity move, not a warning. The stock’s strong rally and pipeline remain key for investors.
3 minutes to read
ADLAI NORTYE LTD
CEO Lu Yang Offloads 10 Shares of Adlai Nortye Ltd.—A Small Move with Big Investor Eyesight
CEO Lu Yang sells 10 ADS of Adlai Nortye – what it means for investors amid price volatility and upcoming clinical data.
3 minutes to read
Adlai Nortye’s CEO Buys Millions of Shares, Grants RSUs—Insiders Signal Strong Confidence Amid Market Volatility
Adlai Nortye insiders boost confidence with new RSU grants, aligning CEO and exec incentives toward long‑term value amid clinical‑stage growth.
3 minutes to read
Insiders Hold Steady on Adlai Nortye: No Share Moves Amid 680% YoY Surge and Upcoming Closed‑Trading Window.
Insider‑held options stay steady at Adlai Nortye—hinting long‑term confidence amid a 680% growth surge and a pending closed‑trading window that could unlock upside.
3 minutes to read